On November 6, amidst the 8th China International Import Expo, Ali Health and Eli Lilly China unveiled a strategic partnership. The collaboration will center on the management of chronic ailments, particularly diabetes, and strive to construct a comprehensive digital ecosystem spanning patient education to diagnosis and treatment services. This endeavor will revolve around three key pillars: digital patient assistance, doctor-patient education initiatives, and collaborative innovation projects. It is noteworthy that Ali Health boasts a reach exceeding 300 million users across the nation, coupled with an efficient pharmaceutical supply chain network that services hundreds of cities. Additionally, the platform harnesses AI technology to continually elevate its operational efficiency and service standards.
